Delivery Order SPE2DB22D2007-SPE2DB24FJ1HZ
Award Date
4/8/24
Potential Completion Date
4/9/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,727.44 firm fixed price delivery order contract for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,970.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BYDUREON BCISE 2 MG AUTOINJECT 0.85ML pharmaceutical products. The contract has a potential value of $8,564.82 and a completion date of January 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BYDUREON BCISE 2 MG AUTOINJECT 0.85ML pharmaceutical products. The $8,110.46 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,570.20 firm fixed price contract is for the supply of the pharmaceutical product Bydureon Bcise 2 mg autoinjector 0.85 mL. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Bydureon BCISE 2 MG Autoject 0.85ML. The contract has a not-to-exceed value of $5,233.90 and a period of performance through March 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $12,240.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 2 mg BYDUREON BCISE autoinjector pens. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of Bydureon Bcise 2 mg autoinjectors. The $3,562.74 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for a period ending on October 23, 2024. The contract is a Delivery Order, and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This appears to be a delivery order under a larger Indefinite Delivery...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML pharmaceutical products. The delivery order has a potential value of $6,937.50 and a completion date of February 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. This delivery order is...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BYDUREON BCISE 2 MG AUTOINJECT 0.85ML pharmaceutical products. The order has a potential value of $22,537.29 and a completion date of January 31, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is not designated as a set-aside contract. The company also holds...